samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > silicon syringes
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Silicon Syringes

Pre-filled syringes have for a number of years been the focus of the parenteral drug developer and they are there to stay. They have enjoyed tremendous market development, a process that has not yet come to an end. While Europe traditionally took the largest share of prefilled syringe applications, the US market is now quickly catching up at a considerable pace. Numbers may depend on the source, but the total worldwide market for prefilled syringes has been estimated as three billion in 2010. Growth rates for prefilled syringes are still double-digit numbers. Syringes in glass have an established position, seeing a yearly growth rate of 10 per cent; for plastic syringes that, relative to glass, are at the start of their market acceptance, numbers of 20 per cent are quoted.

The rapid development of prefilled syringes is founded on numerous factors. Among the most important of these are its dose accuracy, its low dead volume – which, especially for expensive biotech drugs, leads to considerable savings – the possibility to extend the product life cycle of a drug and to offer pharmaceutical product differentiation, and of course the convenience and ease of use for medical personnel. Another reason that is related to the market is the advent of more biologicals in the R&D pipelines of major drug companies – biologicals that can only be administered via a parenteral route.

Many things can be said about prefillable syringes, and it is impossible to be exhaustive. Therefore, this article will deal with some more topical discussions, with particular focus on the siliconisation of syringes or of syringe components.

WHY SILICONISATION?

In order to be functional – that is, to deliver a drug dose to a patient in a correct and adequate way – two components of prefilled syringes typically are siliconised...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Renaud Janssen graduated as a chemical engineer from Leuven University, Belgium. After finishing his doctoral study, he joined Janssen Pharmaceutica, where he worked in the Department of Chemical Development and Production. In 1988 he joined Helvoet Pharma, where he has held various functions in R&D, technical support and quality. Renaud is currently heading Helvoet Pharma’s global department of Technical Support.
spacer
Dr Renaud Janssen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Datwyler launches the Design Your Seal app

Datwyler is pleased to announce the launch of the Design Your Seal app. You can mix and match colors, personalize the aluminum seal and plastic disc, and explore a variety of options to meet your product and branding needs. Launch Design Your Seal app Once the designs are complete, the physical samples are assembled and shipped to the customer for evaluation. Design Your Seal helps to bridge the gap between Datwyler’s design process and the customer’s brand needs.
More info >>

White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement